1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Fibromyalgia Global Clinical Trials Review, H1, 2014

Fibromyalgia Global Clinical Trials Review, H1, 2014

  • June 2014
  • -
  • Global Data
  • -
  • 138 pages

Fibromyalgia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, H1, 2014" provides data on the Fibromyalgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibromyalgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fibromyalgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Fibromyalgia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Fibromyalgia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Fibromyalgia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Fibromyalgia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Fibromyalgia 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Fibromyalgia Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Fibromyalgia 35
May 12, 2014: Tonix Pharmaceuticals Completes Enrollment in BESTFIT Trial of TNX-102 SL for Fibromyalgia 35
Apr 30, 2014: Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Forest Laboratories, Inc. 41
Clinical Trial Overview of Forest Laboratories, Inc. 41
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
Tonix Pharmaceuticals Holding Corp. 44
Clinical Trial Overview of Tonix Pharmaceuticals Holding Corp. 44
Jazz Pharmaceuticals plc 45
Clinical Trial Overview of Jazz Pharmaceuticals plc 45
UCB S.A. 46
Clinical Trial Overview of UCB S.A. 46
Laboratoires Pierre Fabre SA 47
Clinical Trial Overview of Laboratoires Pierre Fabre SA 47
Rose Pharmed Biotechnology Co. 48
Clinical Trial Overview of Rose Pharmed Biotechnology Co. 48
GlaxoSmithKline plc 49
Clinical Trial Overview of GlaxoSmithKline plc 49
Boehringer Ingelheim GmbH 50
Clinical Trial Overview of Boehringer Ingelheim GmbH 50
Clinical Trial Overview of Top Institutes / Government 51
The University of Granada 51
Clinical Trial Overview of The University of Granada 51
National Center for Complementary and Alternative Medicine 52
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 52
National Institute of Arthritis and Musculoskeletal and Skin Diseases 53
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 53
Federal University of Sao Paulo 54
Clinical Trial Overview of Federal University of Sao Paulo 54
University of Michigan 55
Clinical Trial Overview of University of Michigan 55
Stanford University 56
Clinical Trial Overview of Stanford University 56
Duke University 57
Clinical Trial Overview of Duke University 57
The Tel Aviv Sourasky Medical Center 58
Clinical Trial Overview of The Tel Aviv Sourasky Medical Center 58
University of Gothenburg 59
Clinical Trial Overview of University of Gothenburg 59
U.S. Department of Veterans Affairs 60
Clinical Trial Overview of U.S. Department of Veterans Affairs 60
Five Key Clinical Profiles 61
Appendix 136
Abbreviations 136
Definitions 136
Research Methodology 137
Secondary Research 137
About GlobalData 138
Contact Us 138
Disclaimer 138
Source 138

List of Tables
Fibromyalgia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Fibromyalgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Fibromyalgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Fibromyalgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Fibromyalgia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Fibromyalgia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Fibromyalgia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Fibromyalgia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Fibromyalgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Fibromyalgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Fibromyalgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Fibromyalgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Fibromyalgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Fibromyalgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Fibromyalgia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Fibromyalgia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Fibromyalgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Fibromyalgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Fibromyalgia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Fibromyalgia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Fibromyalgia Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Fibromyalgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Fibromyalgia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Fibromyalgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Fibromyalgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Fibromyalgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 37
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2014* 41
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 43
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tonix Pharmaceuticals Holding Corp., 2014* 44
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jazz Pharmaceuticals plc, 2014* 45
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 46
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 47
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rose Pharmed Biotechnology Co., 2014* 48
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 49
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2014* 50
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Granada, 2014* 51
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 52
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 53
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2014* 54
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 55
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 56
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 57
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Tel Aviv Sourasky Medical Center, 2014* 58
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Gothenburg, 2014* 59
Fibromyalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 60

List of Figures
Fibromyalgia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Fibromyalgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Fibromyalgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Fibromyalgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Fibromyalgia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Fibromyalgia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Fibromyalgia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Fibromyalgia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Fibromyalgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Fibromyalgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Fibromyalgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Fibromyalgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Fibromyalgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Fibromyalgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Fibromyalgia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Fibromyalgia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Fibromyalgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Fibromyalgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Fibromyalgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Fibromyalgia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Fibromyalgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Fibromyalgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Fibromyalgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 137

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.